Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Rosmantuzumab |
Trade Name | |
Synonyms | OMP-131R10 |
Drug Descriptions |
Rosmantuzumab (OMP-131R10) is a monoclonal antibody that targets R-spondin 3 (RSPO3), which results in decreased pathway activation and may lead to reduced tumor cell proliferation and decreased survival of cancer stem cells (PMID: 32559496). |
DrugClasses | WNT Inhibitor 16 |
CAS Registry Number | 1684393-04-1 |
NCIT ID | C122921 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Rosmantuzumab | Rosmantuzumab | 0 | 1 |